Paola Cipriani

Paola Cipriani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paola Cipriani sits on this spectrum.

Paola Cipriani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paola Cipriani sits on this spectrum.

Overview

Best Publications

• Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.

  Alessandro Conforti;Ilenia Di Cola;Viktoriya Pavlych;Piero Ruscitti

  352
  Citations

• Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

  Alessandra Marrelli;Paola Cipriani;Vasiliki Liakouli;Francesco Carubbi

  251
  Citations

• The role of IL-1β in the bone loss during rheumatic diseases.

  Piero Ruscitti;Paola Cipriani;Francesco Carubbi;Vasiliki Liakouli

  223
  Citations

• Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

  Fabiola Atzeni;Piercarlo Sarzi-Puttini;Costantino Botsios;Antonio Carletto

  222
  Citations

• Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

  Francesco Carubbi;Paola Cipriani;Alessandra Marrelli;Paola Di Benedetto

  220
  Citations

• Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.

  P. Cipriani;S. Guiducci;I. Miniati;M. Cinelli

  200
  Citations

• Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis

  Roberto Giacomelli;Gabriele Valentini;Felice Salsano;Paola Cipriani

  181
  Citations

• Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

  Piero Ruscitti;Paola Cipriani;Francesco Masedu;Daniela Iacono

  176
  Citations

• International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

  Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  169
  Citations

• Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

  P. Ruscitti;P. Cipriani;P. Di Benedetto;V. Liakouli

  162
  Citations

• Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia.

  F Berlutti;C Morea;A Battistoni;S Sarli

  159
  Citations

• Methotrexate: an old new drug in autoimmune disease

  Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Vasiliki Liakouli

  155
  Citations

• Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

  Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Elena Bartoloni-Bocci

  153
  Citations

• The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

  Mirko Manetti;Lidia Ibba-Manneschi;Vasiliki Liakouli;Serena Guiducci

  151
  Citations

• The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

  Paola Cipriani;Paola Di Benedetto;Piero Ruscitti;Daria Capece

  142
  Citations

• Angiogenic cytokines and growth factors in systemic sclerosis

  Vasiliki Liakouli;Paola Cipriani;Alessandra Marrelli;Saverio Alvaro

  139
  Citations

• Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.

  Florenzo Iannone;Elisa Gremese;Fabiola Atzeni;Domenico Biasi

  131
  Citations

• Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

  Piero Ruscitti;Francesco Masedu;Saverio Alvaro;Paolo Airò

  121
  Citations

• Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion

  R Perricone;C De Carolis;B Kröegler;E Greco

  119
  Citations

• Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.

  Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Ilenia Pantano

  115
  Citations

• Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

  Serena Colafrancesco;Roberta Priori;Guido Valesini;Lorenza Argolini

  112
  Citations